Publications by authors named "Jacob S Bedia"

Article Synopsis
  • - Tubo-ovarian high-grade serous carcinoma (HGSC) is a highly lethal form of cancer that often responds to platinum-based chemotherapy due to common issues with DNA damage repair pathways.
  • - Current mechanisms behind platinum resistance in HGSC are complex and not well understood, leading to a lack of effective biomarkers or treatments to improve patient outcomes.
  • - The study uses advanced single-cell mass cytometry to analyze protein responses in HGSC cells, identifying eight specific protein modules linked to carboplatin resistance and sensitivity, which could help in better categorizing and treating drug resistance in patients.
View Article and Find Full Text PDF

Background: Multiple antigens, autoantibodies (AAb), and antigen-autoantibody (Ag-AAb) complexes were compared for their ability to complement CA125 for early detection of ovarian cancer.

Methods: Twenty six biomarkers were measured in a single panel of sera from women with early stage (I-II) ovarian cancers (n = 64), late stage (III-IV) ovarian cancers (186), benign pelvic masses (200) and from healthy controls (502), and then split randomly (50:50) into a training set to identify the most promising classifier and a validation set to compare its performance to CA125 alone.

Results: Eight biomarkers detected ≥ 8% of early stage cases at 98% specificity.

View Article and Find Full Text PDF

Purpose: The Normal Risk Ovarian Screening Study (NROSS) tested a two-stage screening strategy in postmenopausal women at conventional hereditary risk where significantly rising cancer antigen (CA)-125 prompted transvaginal sonography (TVS) and abnormal TVS prompted surgery to detect ovarian cancer.

Methods: A total of 7,856 healthy postmenopausal women were screened annually for a total of 50,596 woman-years in a single-arm study (ClinicalTrials.gov identifier: NCT00539162).

View Article and Find Full Text PDF

High-grade serous ovarian cancer (HGSOC) is the most lethal gynecological malignancy. Its diagnosis at advanced stage compounded with its excessive genomic and cellular heterogeneity make curative treatment challenging. Two critical therapeutic challenges to overcome are carboplatin resistance and lack of response to immunotherapy.

View Article and Find Full Text PDF

Background: Algorithmic cellular segmentation is an essential step for the quantitative analysis of highly multiplexed tissue images. Current segmentation pipelines often require manual dataset annotation and additional training, significant parameter tuning, or a sophisticated understanding of programming to adapt the software to the researcher's need. Here, we present CellSeg, an open-source, pre-trained nucleus segmentation and signal quantification software based on the Mask region-convolutional neural network (R-CNN) architecture.

View Article and Find Full Text PDF